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Perioperative anaphylaxis is characterized by severe respiratory and cardiovascular manifestations.  Correct 
management of anaphylaxis during anaesthesia requires a multidisciplinary approach with prompt recognition and 
treatment of the acute event by the attending anesthesiologist.  A 34-year-old woman was scheduled to undergo endo 
venous laser therapy of varicose veins. She had no history of allergies and had never undergone general anesthesia.   
General anesthesia was induced with propofol and rocuronium bromide.  Approximately three minutes after 
rocuronium administration, hypotension and tachycardia developed and angioedema around the eyelids and skin 
rashes and urticaria appeared.  The patient received ephedrine and hydrocortisone with hydration. After achieving 
stable vital signs and symptom relief, surgery was performed without complications.  A postoperative skin dermal 
test performed to identify the agent responsible revealed a positive skin test for rocuronium.  (Korean J Anesthesiol 
2010; 58: 391-395)
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    General anesthesia involves the administration of a variety 
of medications to a patient in relatively short duration. Various 
side effects can occur due to reactions to the drugs provided 
with anaphylaxis being a life threatening severe reaction. 
Although anaphylaxis is a rare side effect, it can lead to death if 
not diagnosed treated quickly and appropriately. The clinical 
features of immediate hypersensitivity allergic reactions 
include not only hemodynamic changes but also urticaria, flare, 
angioedema, among which the observation of a skin reaction 
is useful for diagnosis and treatment. Moreover, identifying the 
causative agent is the most important procedure to prevent a 
recurrence [1,2].
 We report an experience of anaphylaxis accompanied with 
angioedema after administrating propofol and rocuronium to 
induce general anesthesia in a 34-year-old female patient with 
varicose veins, who was scheduled to undergo endovenous 
laser therapy and varicosectomy, with a review of the relevant 
literature.392 www.ekja.org
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    A 34-year-old, 162 cm, 55 kg female patient with varicose 
veins was scheduled to undergo endovenous laser therapy 
and a varicosectomy. She had no other underlying disorders 
or medical history of surgery. With the exception of an allergy 
to dust, she had no other allergic reactions to medications and 
food, and there was no family history of allergies. There were 
no abnormalities in the preoperative physical examination, 
hematological test, simple X-ray test and ECG. 
    Thirty minutes before arriving in the operation room, 2.0 
mg of midazolam and 0.2 mg of glycopyrrolate were injected 
into the muscle as preanesthetic medication. After arriving 
in the operation room, the ECG, heart rate, non invasive 
blood pressure manometer, pulse oximeter, and end tidal 
CO2 were monitored. The preanesthetic vital signs indicated 
a blood pressure (BP), pulse rate and oxygen saturation of 
110/70 mmHg, 75 bpm and 99%, respectively. To induce 
general anesthesia, 110 mg of propofol mixed with 40 mg of 
2% lidocaine was injected intravenously. After confirming the 
patient's loss of consciousness, manual ventilation was per-
formed using a mask with oxygen 3 L/min, nitro oxide 3 L/
min and, sevoflurane 3 vol%. Endotracheal intubation was 
performed one or two minutes after administering 40 mg of 
rocuronium. 
    Her heart rate (HR) increased immediately after the endo-
tracheal intubation. Three minutes later, her HR and BP was 
135/min and 75/35 mmHg, respectively. Suspecting the 
influence of inhalation anesthetics, the anesthetic medication 
was discontinued, but the HR continued to increase. At the 
same time, her systolic and diastolic blood pressure was 60-
70 mmHg and 30-35 mmHg, respectively. In addition, there 
was slight flaring observed in the face and chest as well as 
angioedema around the eyes. Subsequently, the end tidal 
CO2 showed an obstructive pattern, and urticaria broke out 
with anaphylaxis. 100% oxygen was provided promptly at 6 L/
min, with crystalloid and colloid solution. After administering 
ephedrine 4 mg twice, her vital signs recovered within 10 
minutes to indicate a HR and BP of 100/min and 110/65 mmHg, 
respectively.
    With time, the whole body flare and urticaria worsened and 
angioedema was observed around her eyes (Fig. 1). Therefore, 
250 mg of hydrocortisone (Solucortef
Ⓡ, Pfizer, USA) and 3 
mg of an antihistamine, piprinhydrinate (Plokon
Ⓡ, Yungjin 
Pharm. Co., Korea), were injected intravenously followed by 
3 mg of midazolam to prevent emergence. Subsequently, her 
vital signs stabilized about 20 minutes after the induction of 
anesthesia, the urticaria, flare, and angioedema relived. It 
was decided that she should be under further observation to 
determine whether to proceed with surgery. Forty minutes 
after inducing anesthesia, her vital signs continued to stabilize 
and the urticaria and angioedema around the swollen eyes 
were relieved. Therefore, after a discussion with her attending 
surgeon and parents, a decision was made to proceed with the 
operation. 
    Anesthesia was maintained with sevoflurane 2-3%, oxygen 
and nitro oxide at 2 L/min. During the two hour operation, no 
additional muscle relaxant was administered, and the operation 
was completed without complications. As the operation 
proceeded, the obstructive pattern of the CO2 curve disappeared 
and the end tidal CO2 returned to normal. Extubation was 
performed after postoperative manual ventilation ensured the 
suitability of the patient's tidal volume and rate, and her vital 
signs were also within the normal range. 
    She was transferred to the recovery room after extubation with 
spontaneous respiration, consciousness, BP, oxygen saturation 
all normal. The anaphylactic reaction that developed during 
anesthesia was explained to both the patient and her parents. 
The risk of side effects during anesthesia due to the pathogenic 
potential of anaphylaxis to the medication employed was also 
explained. An intradermal skin test was advised for a differential 
diagnosis.
    The patient wanted to take the test during her hospitalization, 
and on post operative day 2, an intradermal skin test was 
performed at the department of dermatology at our hospital 
to check the medications administered at the induction of 
anesthesia as well as the drugs used in subsequent anesthesia. 
Histamine was taken as a positive control while a saline solution 
was used as the negative control; 0.03 ml of each test substance 
was injected on the back of the patient with a hypodermic 
needle in the form of a clinically used solution diluted at ratio 
of 1 : 10, 1 : 100, and 1 : 1,000 from a stock solution. Twenty 
minutes after the injection, the size of any wheal was measured. 
The criterion of positivity to an intradermal skin test is the 
mean diameter of the measured injection papule being larger 
than the diameter of the wheal induced by the positive control 
solution or twice than that of the bleb produced by the first 
injection. The test was stopped every time a positive reaction 
occurred at a lowest density level. Among the medications used 
to induce anesthesia on the operation day, rocuronium elicited  Fig. 1. Patient with facial angioedema.393 www.ekja.org
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a positive reaction in a 1/100 dilution, and was identified as 
the causing agent for the anaphylaxis. In addition, another 
muscle relaxant, vecuronium, showed a positive reaction in 
an undiluted solution. The tests with the other drugs showed 
negative reaction (Table 1).
    The patient and her parents were informed that she also had 
a positive reaction to vecuronium, which is commonly used as 
a nondepolarizing muscle relaxant for inducting operation. The 
patient was asked to explain her medical history to medical staff 
at any future procedure, and she was discharged the next day.
Discussion
    Anaphylaxis may be defined as a severe, even deadly, allergic 
reaction involving the whole body. It is a type 1 hypersensitivity 
reaction resulting from the release of vasomotor substances, 
such as histamine, lukotriene, etc., which are activated by mast 
cells or basophilic cells via the mediators of immunoglobulin 
E (IgE). The clinical symptoms of anaphylactic reactions are 
difficult to differentiate from anaphylactoid reactions not 
mediated by IgE, and the distinction was reformulated in recent 
terminology as immunologic anaphylaxis vs. non-immunologic 
anaphylaxis [2].
    The prevalence of anaphylaxis during general anesthesia varies 
from 1 : 4,500 to 1 : 20,000. The mortality rates for anaphylaxis 
are 3-6 % and the frequency of severe neurological damage is 
2%. The clinical features involve the following: cardiovascular 
collapse, such as hypotension, tachycardia, or bradycardia; 
complications of the respiratory system, such as bronchospasm, 
pulmonary edema, and hypoxia; and skin reactions, such as 
systemic lupus erythematosus and edema, etc. Such reactions 
require immediate medical treatment, which includes the 
correction of hypoxia, inhibition of the release of chemical 
mediators by removing the causative agents, supplementation 
of intravascular volume, immediate provision of 100% oxygen, 
administration of epinephrine, and early endotracheal 
intubation against the occurrence of vascular edema, etc. [3].
    The episode of anaphylaxis in our patient was identified 
with the concurrence of facial edema, airway resistance, 
bronchospasm like a change in the end tidal CO2 curve, and 
cardiovascular reactions. Rocuronium was presumed to be 
the causative agent of anaphylaxis because the injection of 
rocuronium initiated the increase in airway resistance and the 
sudden decrease in blood pressure.
    Considering that it is impossible to make a precise diagnosis 
of the causative substance of anaphylaxis during surgery, it is 
advisable to terminate the operation as early as possible and 
discontinue any medications [4]. In our case, the patient's 
condition was not critical and after prompt administration 
of fluid and ephedrine, her vital signs were maintained 
continuously in the normal range. In addition a steroid effective 
in a delaying the reaction was injected into the patient, followed 
by the administration of antihistamine to treat the vascular 
edema, even though it was reported that the administration 
of antihistamine is not effective in episode of anaphylaxis [5]. 
As a result, her condition improved considerably, and the 
operation was resumed after a discussion with her attending 
surgeon and parents. She recovered from the operation without 
complications.
    Vascular edema is a skin change resulting from skin vasodi-
lation and an increase in vessel wall permeability. When vascular 
edema is dilated, the transition of a large amount of fluid takes 
place, and the mucosal edema in the pharynx, larynx, trachea, 
etc. causes an obstruction of the upper airway, which affects the 
entire trachea. An increase in exudate can lead to hypovolemic 
shock [2]. Vascular edema can be attributed not only to acute 
allergic reactions but also to hereditary vascular edema due 
to a C1 esterase inhibitor deficiency and to acquired vascular 
edema by drugs, such as an ACE inhibitor, autoimmune diseases, 
and various underlying disorders such as cancer [6]. Despite 
the diverse causes, the clinical manifestations, such as airway 
edema, are so similar that differentiation is required. In the 
present case, where the patient had no abnormality in her 
medical history, a C4 blood test, which is one of the screening 
Table 1. The Skin Wheal Size after the Intradermal Injection (mm)











































A/B, A: the skin wheal size before the intradermal injection.  B: the skin wheal size 20 minutes later. *Positive reaction.394 www.ekja.org
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tests for acquired vascular edema, was normal. Therefore, an 
allergic reaction to the administered drugs was assumed to be 
the cause.
    Anaphylaxis can occur as a result of any medication used 
during anesthesia, among which 60% of cases are connected 
to muscle relaxants, 20% to latexes, 15% to antibiotics, and the 
rest 5% to sleeping pills, colloids, opioids, etc. Considering that 
her previous medical history, such as atopy, asthma, allergy to 
food or dust, etc., can increase the risk of allergy to latex, but 
not to muscle relaxants, her experience of allergy to dust did not 
appear to have any relevance to anaphylaxis [7].
    The diagnosis of anaphylaxis while its reaction is active, 
includes the measurement of tryptase, histamine, complement 
or IgE, skin prick test, intradermal skin test, etc. A skin prick 
test can be used for a differential test because it is simple, 
reliable, and can test several antigens simultaneously with 
relative safety. On the other hand, an intradermal skin test has 
high sensitivity with a low false-negativity rate, showing much 
greater sensitivity than a specific IgE measurement. In addition, 
an intradermal skin test is regarded as a critical criteria of 
diagnosis for allergic reactions that develop during operation, 
particularly muscle relaxant-induced allergic reactions [8,9]. 
    In the intradermal skin test performed in our case, rocuro-
nium showed a positive reaction in a 1/100 dilution, while 
succinylcholine, which known to be relatively more risky, 
showed a negative reaction. The reason why the patient 
developed an allergic reaction, even though she had never been 
exposed to muscle relaxants, is that quaternary ammonium 
ions are present in common household goods, such as tooth 
paste, collyrium, shampoo, antiussive (cough medicine), which 
may have induced sensitization response. The difference in 
the prevalence of an allergic response to muscle relaxants 
between several countries varies up to six times. It was reported 
that such a difference may be related to the frequency of using 
these daily goods [10]. The reason why both rocuronium and 
vecuronium showed positive reactions may be due to the 
following possibilities: first, cross-sensitization response by 
quaternary ammonium ions that muscle relaxants commonly 
share second, false positive reaction to substances other than 
the antigens, caused by a hyper-response developed because 
the intradermal skin test in our case was conducted much 
earlier than the generally recommended waiting period of 4 
weeks after the onset of symptom [11]. It was reported that the 
rate of false positive reactions increases when an undiluted 
or a low dilution ratio solution is used in the intradermal skin 
test and that a skin prick test on healthy adults with undiluted 
rocuronium and vecuronium showed 50% and 40% false positive 
reaction, respectively [12]. In addition, a recent study suggested 
that a positive reaction only at more than 1/100 dilution 
should be regarded as meaningful [13]. A review of the recent 
literature showed that rocuronium may have been the cause 
of anaphylaxis for our patient. However, the possibility that the 
positive reaction to vecuronium is a false positive cannot be 
ruled out.
    An anaphylactic reaction to rocuronium was reported to 
increase with increasing frequency of its use, and a cross-
reaction may developed as a result of the quaternary ammo-
nium ions as the epitope of the muscle relaxant. Therefore, 
when a patient shows an allergic reaction to a muscle relaxant, 
it is necessary to confirm thecross reaction to other muscle 
relaxants [14,15].
    Providing the proper treatment in the event of anaphylaxis is 
important but pretreatment to prevent exposure to its inducers 
is much more important. It is practically impossible to perform 
a skin test on every medication administered during anesthesia 
for every patient. However, in patients with a potential risk 
of anaphylaxis, such as patients who have experienced an 
allergic response to a medication, it is necessary to perform a 
skin test to selectively identify the inducing materials. When 
responsible agents are identified, the administration of the 
causative agents and cross reaction-induced substances should 
be avoided. If there is no alternative but to employ the inducers, 
an antihistamine and steroid should be administered as a 
premedication prior to surgery, and the medication should be 
diluted and injected slowly or in small doses with a gradual 
increase to reduce anaphylactic reaction as much as possible. 
    An anaphylactic reaction during surgery is rare but possible. 
In addition, the diagnosis of anaphylactic reactions is difficult 
to make during the induction of anesthesia when various types 
of medication are used simultaneously. Therefore, it is essential 
to understand clearly the criteria for a diagnosis and treatment 
of anaphylaxis, to make a prompt diagnosis, and to provide a 
proper treatment for its occurrence. In this case, the operation 
was performed safely after the incidence of anaphylaxis caused 
by rocuronium, and the responsible agent was identified using 
the intradermal skin test, which has higher sensitivity than 
other diagnostic methods. 
References
1.   Mertes PM, Laxenaire MC, Lienhart A, Aberer W, Ring J, Pichler 
WJ, et al. Reducing the risk of anaphylaxis during anaesthesia: 
guidelines for clinical practice. J Investig Allergol Clin Immunol 
2005; 15: 91–101.
2. Joseph T. Nitti: Anesthetic Complications. In: Clinical Anesthe-
siology. 4th ed. Edited by Morgan Jr, Maged SM, Michael JM: USA, 
McGraw-Hill. 2006, pp 970-3.
3. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid 
reactions occurring during anesthesia in France in 1999-2000. 
Anesthesiology 2003; 99: 536-45.
4. Lieberman P. Anaphylactic reactions during surgical and medical 395 www.ekja.org
Korean J Anesthesiol Jeong, et al.
procedures. J Allergy Clin Immunol 2002; 110(2 Suppl): S64–9.
5. Fisher MM, Munro I. Life-threatening anaphylactoid reactions to 
muscle relaxants. Anesth Analg 1983; 62: 559-64.
6. Jesen NF, Weiler JM. C1 esterase inhibitor deficiency, airway 
compromise, and anesthesia. Anesth Analg 1998; 87: 480-8.
7. Porri F, Lemiere C, Birnbaum J, Guilloux L, Lanteaume A, Didelot 
R, et al. Prevalence of muscle relaxant sensitivity in a general popu-
lation: implications for a preoperative screening. Clin Exp Allergy 
1999; 29: 72–5.
8. Dybendal T, Guttormsen AB, Elsayed S, Askeland B, Harboe T, 
Florvaag E. Screening for mast cell tryptase and serum IgE antibodies 
in 18 patients with anaphylactic shock during general anesthesia. 
Acta Anaesthesiol Scand 2003; 47: 1211-8.
9. Hwang SM, Suh JW, Lim SY. Anaphylaxis after Thiopental and 
Rocuronium Induction. Korean J Anesthesiol 2005; 48: 95-8.
10. Florvaag E, Johansson SG, Oman H, Venemalm L, Degerbeck F, 
Dybendal T, et al. Prevalence of IgE antibodies to morphine. Relation 
to the high and low incidences of NMBA anaphylaxis in Norway 
and Sweden, respectively. Acta Anaesthesiologica Scandinavica 
2005; 49: 437–44.
11. Ebo DG, Hagendorens MM, Bridts CH, De Clerck LS, Stevens 
WJ. Scandinavian clinical practice guidelines on the diagnosis, 
management and follow-up of anaphylaxis during anaesthesia: 
some diagnostic issues. Acta Anaesthesiol Scand 2008; 52: 314-5.
12. Dhonneur G, Combes X, Chassard D, Merle JC. Skin sensitivity 
to rocuronium and vecuronium: a randomized controlled prick 
testing study in healthy volunteers. Anesth Analg 2004; 98: 986-9.
13. Levy JH. Anaphylactic reactions to neuromuscular blocking drugs: 
are we making the correct diagnosis? Anesth Analg 2004; 98: 881-2.
14. Matthey P, Wang P, Finegan BA, Donnelly M. Rocuronium ana-
phylaxis and multiple neuromuscular blocking drug sensitivities. 
Can J Anaesth 2000; 47: 890-3.
15. Lee HM, Song SO. Ananaphylaxis after Injection of Rocuronium. 
Korean J Anesthesiol 2006; 51: 101-4.